Treating asymptomatic follicular lymphoma: What is the score?
British Journal of Haematology · 2025
DOI: 10.1111/bjh.19949 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Ghassan Zammar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia. Hauptthemen laut MEDLINE: Lymphoma, Follicular, Rituximab, Quality of Life, Antineoplastic Agents, Immunological. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Health‐related quality of life measures are underemphasised in clinical trials and particularly valuable in follicular lymphoma as some interventions can result in substantial toxicity with uncertain impact on overall survival. The report by Marzolini and colleagues provides a nuanced discussion on the merits of rituximab monotherapy versus observation in asymptomatic follicular lymphoma patients. Commentary on: Marzolini et al. Quality of life in advanced‐stage, asymptomatic, non‐bulky follicular lymphoma treated with rituximab shows significant improvement compared with watchful‐waiting. Br J Haematol 2025; 206:876‐886.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Haematology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
- Medical School, University of Western Australia, Perth, Western Australia, Australia.
ORCID-Profile: Chan Y Cheah
Zitieren
APA
Zammar, G., & Cheah, C. Y. (2025). Treating asymptomatic follicular lymphoma: What is the score?. British Journal of Haematology. https://doi.org/10.1111/bjh.19949
Vancouver
Zammar G, Cheah CY. Treating asymptomatic follicular lymphoma: What is the score?. British Journal of Haematology. 2025. doi:10.1111/bjh.19949
BibTeX
@article{Zammar2025,
author = {Zammar, Ghassan and Cheah, Chan Y},
title = {Treating asymptomatic follicular lymphoma: What is the score?},
journal = {British Journal of Haematology},
year = {2025},
doi = {10.1111/bjh.19949}
}
EUVIMED